The effect of amino acid excipients on morphology and solid-state properties of multi-component spray-dried formulations for pulmonary delivery of biomacromolecules
Version 2 2024-06-04, 15:47Version 2 2024-06-04, 15:47
Version 1 2020-05-14, 15:56Version 1 2020-05-14, 15:56
journal contribution
posted on 2024-06-04, 15:47 authored by T Sou, LM Kaminskas, TH Nguyen, R Carlberg, MP McIntosh, David MortonDavid MortonFor a dry powder carrier platform to be suitable for pulmonary delivery of potent biomacromolecules, it has to be aerosolisable and capable of stabilising the biomacromolecules. In the present study, strategies aiming to produce a multi-component spray-dried powder formulation with a stable amorphous glassy matrix containing mannitol, trehalose, glycine and alanine, while using leucine as a particle formation and aerosolisation enhancing agent were investigated. The results from in vitro aerosolisation studies demonstrated high fine particle fractions (FPFs) from several formulations. Scanning electronic micrographs (SEMs) revealed distinct morphological features of these formulations in response to increasing leucine concentration: from the apparent insufficiency for discrete particle formation, to reduced particle agglomeration, to increased surface corrugation. X-ray powder diffraction (XRPD) results indicated that partially ordered leucine resulting from self-assembly on the particle surface is important for the amino acid to function effectively as an encapsulating agent. This may also play a role in inhibiting crystallisation of other components within the formulation. In conclusion, the results suggest that with suitable particle size, good dispersibility and solid-state properties, selected trehalose/leucine combinations appear to have good potential for development into a universal carrier platform for pulmonary delivery of potent biomacromolecules and the work highlights areas deserving further investigation. © 2012 Elsevier B.V. All rights reserved.
History
Journal
European Journal of Pharmaceutics and BiopharmaceuticsVolume
83Pagination
234-243Location
Amsterdam, The NetherlandsPublisher DOI
ISSN
0939-6411eISSN
1873-3441Language
engPublication classification
C1.1 Refereed article in a scholarly journalIssue
2Publisher
ElsevierUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC